Markets:

Overview

News

Currencies

International

Treasuries

ASLAN Pharmaceuticals Limited - American Depositary Shares (NQ:ASLN)

0.6000 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 18, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about ASLAN Pharmaceuticals Limited - American Depositary Shares

< Previous 1 2 3 4 Next >

Why Clovis Oncology Is Trading Higher By 14%; Here Are 28 Stocks Moving Premarket ↗

September 12, 2022

Gainers Aditxt, Inc. (NASDAQ: ADTX) rose 46.1% to $0.2801 in pre-market trading after jumping 37% on Friday.

Via Benzinga

Why Nuwellis Surged Over 121%; Here Are 66 Biggest Movers From Yesterday ↗

September 01, 2022

Gainers

Via Benzinga

ASLAN Pharma: Q2 Earnings Insights ↗

August 12, 2022

ASLAN Pharma (NASDAQ:ASLN) reported its Q2 earnings results on Friday, August 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

ASLAN Pharma: Q1 Earnings Insights ↗

April 27, 2022

ASLAN Pharma (NASDAQ:ASLN) reported its Q1 earnings results on Wednesday, April 27, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday ↗

August 15, 2022

Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 12, 2022

Via Benzinga

44 Stocks Moving In Thursday's Mid-Day Session: F-star Therapeutics, Revlon And More ↗

June 23, 2022

Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) rose 83.8% to $1.3824. Blue Hat Interactive terminated its previously proposed shelf takedown offering.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

April 21, 2022

Gainers

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

June 06, 2022

Monday's session saw 84 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

April 14, 2022

Gainers

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

June 03, 2022

During Friday's trading, 69 companies set new 52-week lows.

Via Benzinga

Recap: ASLAN Pharmaceuticals Q4 Earnings ↗

March 25, 2022

ASLAN Pharmaceuticals (NASDAQ:ASLN) reported its Q4 earnings results on Friday, March 25, 2022 at 07:00 AM. Here's what investors need to know about the announcement....

Via Benzinga

The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings ↗

March 20, 2022

Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

April 20, 2022

On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 18, 2022

Gainers Sunshine Biopharma (NASDAQ:SBFM) stock increased by 15.5% to $3.5 during Friday's pre-market session. The company's market cap stands at $15.6 million....

Via Benzinga

The Daily Biotech Pulse: Kura Lifts Clinical Hold On Blood Cancer Trial, Intuitive Surgical Earnings, Sorrento's Omicron Antibody Treatment Effective ↗

January 21, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kura Announces Lifting Of Clinical Hold On Phase 1 Blood Cancer Study Kura...

Via Benzinga

ASLAN Pharma Kickstarts Mid-Stage Atopic Dermatitis Trial, Data Expected In 2023 ↗

January 21, 2022

ASLAN Pharmaceuticals Ltd (NASDAQ: ASLN) has screened the first patient in its Phase 2b dose-ranging study of eblasakimab (ASLAN004) in adults with moderate-to-...

Via Benzinga

The Daily Biotech Pulse: Gamida Gains On Positive Regulatory Development, Orphazyme & ADMA Preannouncements, ImmunityBio & Leap Present Positive Data ↗

January 19, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Orphazyme Preannounces Positive FY21 Results Orphazyme A/S (NASDAQ: ORPH)...

Via Benzinga

The Week Ahead In Biotech (Jan. 16-22): Focus On Data Presentations And IPOs In Holiday-Shortened Week ↗

January 16, 2022

Biotech stocks posted losses for the third straight week, as the sector reacted to broader market weakness and announcements out of the 2022 JPMorgan Healthcare conference. Here are the key catalysts...

Via Talk Markets

The Week Ahead In Biotech (Jan 16-22): Focus On Data Presentations And IPOs In Holiday-Shortened Week ↗

January 16, 2022

Biotech stocks posted losses for the third straight week, as the sector reacted to broader market weakness and announcements out of the 2022 JPMorgan Healthcare conference. Swiss...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 11, 2022

Gainers Black Diamond Therapeutic (NASDAQ:BDTX) stock increased by 18.2% to $5.32 during Tuesday's pre-market session. The market value of their outstanding shares is...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 17, 2021

Gainers GBS (NASDAQ:GBS

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

December 14, 2021

Gainers Star Equity Hldgs (NASDAQ:STRR) s...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 30, 2021

Gainers FibroGen (NASDAQ:FGEN) stock mov...

Via Benzinga

Mid-Afternoon Market Update: Dow Gains 150 Points; Red Cat Holdings Shares Spike Higher ↗

September 27, 2021

Toward the end of trading Monday, the Dow traded up 0.43% to 34,949.08 while the NASDAQ fell 0.35% to 14,995.27. The S&P also fell, dropping 0.05% to 4,453.40. The U.S. has...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 27, 2021

Gainers Keros Therapeutics (NASDAQ:KROS) stock moved upwards by 26.51% to $41.75 during Monday's regular session. Keros Therapeutics's stock is trading at a volume...

Via Benzinga

50 Biggest Movers From Yesterday ↗

September 28, 2021

Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares surged 50% to close at $3.60 on Monday after the company said its subsidiary, Skypersonic, Inc, won a five-year contract from...

Via Benzinga

Mid-Day Market Update: Crude Oil Rises 2%; ASLAN Pharmaceuticals Shares Slide ↗

September 27, 2021

Midway through trading Monday, the Dow traded up 0.70% to 35,041.74 while the NASDAQ fell 0.51% to 14,970.85. The S&P also rose, gaining 0.02% to 4,456.20. The U.S. has the...

Via Benzinga

Topics Stocks

31 Stocks Moving In Monday's Mid-Day Session ↗

September 27, 2021

Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares jumped 54.1% to $3.6998 after the company said its subsidiary, Skypersonic, Inc, won a five-year contract from NASA to...

Via Benzinga

Mid-Morning Market Update: Markets Mixed; US Durable Goods Orders Increase Sharply In August ↗

September 27, 2021

Following the market opening Monday, the Dow traded up 0.65% to 35,024.73 while the NASDAQ fell 0.98% to 14,899.77. The S&P also fell, dropping 0.22% to 4,445.70. The U.S. has...

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

ASLAN Pharmaceuticals Limited - American Depositary Shares (NQ:ASLN)

Headline News about ASLAN Pharmaceuticals Limited - American Depositary Shares

Starting at $3.75/week.

Subscribe Today